Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Male cells need DHT to respond to testosterone, while female cells do not.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Androgens don't directly affect hair cell growth or protein production.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Women with acne have lower levels of a specific hormone marker than women without acne.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

MK-386 lowers DHT in blood and skin but not in semen.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

Low androgen levels can still cause female pattern hair loss.

Skin hormone levels change significantly after menopause.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.